Jaguar动物健康 JAGX 深 沪
等待开盘 09-17 09:30:00 美东时间
0.2329
+0.008
+3.70%
华盛通- 最 高0.3109
- 今 开0.235
- 成交量 407.51万股
- 最 低 0.2093
- 昨 收 0.2246
- 总市值 120.37万
- 52周最高 85.3965
- 市盈率 静 --
- 换手率 78.85%
- 52周最低 0.1999
- 委 比 93.24%
- 总股本 516.83万
- 历史最高 87566062500.00
- 量 比 4.71
- 振 幅 45.24%
- 历史最低 0.1999
- 每 手 1
- 风险率 25.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jaguar Animal Health expands ownership and restructures equity
Jaguar Animal Health ( ($JAGX) ) has shared an announcement. On September 11, 2...
09-16 02:17
Jaguar Health sets 1-for-15 reverse stock split; shares crash
Jaguar Health (JAGX) announced on Tuesday that it will execute a 1-for-15 reverse stock split on September 17, 2026, to support compliance with Nasdaq listing requirements. The stock will begin tradin...
09-15 21:09
Jaguar Health To Effect 1-For-15 Reverse Stock Split Of Common Stock On September 17
Reverse split approved at April 2026 Special Meeting of Stockholders Shares of Jaguar Health common stock to begin trading on split-adjusted basis on September 17, 2026 Reverse split approved at April 2026 Special Meeting of Stockholders Shares of Jaguar Health common stock to begin trading on split...
09-15 21:03
Jaguar Health shares are trading lower. The company announced its Napo unit provided crofelemer for treatment of congenital sodium diarrhea in an infant and said it plans to file for FDA approval for MVID in 2027.
Jaguar Health shares are trading lower. The company announced its Napo unit provided crofelemer for treatment of congenital sodium diarrhea in an infant and said it plans to file for FDA approval for MVID in 2027.
09-04 22:36
Jaguar Health Initiates Commercial Roll Out Of Neonorm Dog
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the initiation of the commercial launch of Neonorm Dog, a new extension of Jaguar's Neonorm franchise for companion and production animals. Neonorm Dog is designed to provide dog owners with access to a plant-based, non-prescription produc...
08-26 21:10
Jaguar Health Reports Q2 2026 Results: Full Earnings Call Transcript
Jaguar Health (NASDAQ:JAGX) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. The full ear...
08-20 05:18
Jaguar Health Q2 EPS $(15.70) Up From $(358.94) YoY, Sales $1.225M Down From $2.979M YoY
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(15.70) per share. This is a 95.63 percent increase over losses of $(358.94) per share from the same period last year. The company reported $1.225 million in sales this quarter. This is a 58.88 percent decrease over sales of $2.979 million th...
08-20 03:49
Jaguar Health’s Napo Pharma Satisfies Conditions Required To Receive Payment Of Non-Dilutive $2M Holdback Amount From Future Pak Related To US Commercial Licensing Agreement
As announced, Jaguar received an upfront payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's two commercialized crofelemer drugs - an agreement that is fully aligned with company's strategy to concentr...
08-05 21:04
Jaguar Health Says Findings Of Exploratory Surveys Of Dog Owners And Veterinary Oncologists Support Commercial Opportunity For Neonorm Dog, New Extension Of Jaguar's Neonorm Franchise
Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs Jaguar expects to make Neonorm Dog available through both Amazon and Chewy SAN...
07-28 21:03
Jaguar Health Completes Conversion of Series O Preferred
Jaguar Animal Health ( ($JAGX) ) has issued an announcement. On March 4, 2026, ...
07-02 05:01
